Sale!

SCN9A Gene Dravet Syndrome Modifier of Genetic Test

Name: SCN9A Gene Dravet Syndrome Modifier of Genetic Test
SKU: TEST-1249
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SCN9A Gene Dravet Syndrome Modifier Genetic Test is a specialized diagnostic assessment conducted at DNA Labs UAE, designed to identify mutations in the SCN9A gene, which are known to modify the severity and characteristics of Dravet Syndrome. Dravet Syndrome is a severe form of epilepsy that begins in infancy and is often associated with gene mutations, including those in the SCN1A gene. However, recent research has identified that variations in the SCN9A gene can also influence the disease’s course and response to treatment.

This test, priced at 4400 AED, is crucial for individuals diagnosed with Dravet Syndrome or families with a history of the condition, as it provides valuable insights into the genetic underpinnings of the disease. Understanding the specific genetic variations can guide personalized treatment strategies, potentially improving the quality of life for those affected. The testing process at DNA Labs UAE involves a comprehensive analysis of the SCN9A gene, employing state-of-the-art genetic sequencing technologies to ensure accurate and reliable results.

By opting for the SCN9A Gene Dravet Syndrome Modifier Genetic Test, patients and healthcare providers can gain a deeper understanding of the genetic factors contributing to Dravet Syndrome, paving the way for more targeted and effective interventions.

Description

SCN9A Gene Dravet Syndrome Modifier of Genetic Test

Components: SCN9A Gene Dravet syndrome modifier of Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SCN9A Gene Dravet syndrome, modifier of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN9A Gene Dravet syndrome, modifier of.

Test Details: The SCN9A gene is one of the genes that has been linked to Dravet syndrome, a severe form of epilepsy that usually begins in infancy. This gene provides instructions for making a protein that helps to transmit signals between nerve cells. Mutations in the SCN9A gene can cause a dysfunction in the protein, leading to abnormal nerve cell activity and seizures. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes simultaneously. This type of testing can identify mutations in the SCN9A gene and other genes associated with Dravet syndrome. Modifiers are genetic factors that can influence the severity or expression of a disease. In the case of Dravet syndrome, modifiers may affect the age of onset, frequency, and severity of seizures. Identifying modifiers can help doctors predict the course of the disease and develop more targeted treatments. Overall, NGS genetic testing can provide valuable information for diagnosing Dravet syndrome and identifying potential modifiers. This information can help doctors develop personalized treatment plans for patients with this condition.

Test Name	SCN9A Gene Dravet syndrome modifier of Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SCN9A Gene Dravet syndrome, modifier of NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN9A Gene Dravet syndrome, modifier of
Test Details	The SCN9A gene is one of the genes that has been linked to Dravet syndrome, a severe form of epilepsy that usually begins in infancy. This gene provides instructions for making a protein that helps to transmit signals between nerve cells. Mutations in the SCN9A gene can cause a dysfunction in the protein, leading to abnormal nerve cell activity and seizures. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes simultaneously. This type of testing can identify mutations in the SCN9A gene and other genes associated with Dravet syndrome. Modifiers are genetic factors that can influence the severity or expression of a disease. In the case of Dravet syndrome, modifiers may affect the age of onset, frequency, and severity of seizures. Identifying modifiers can help doctors predict the course of the disease and develop more targeted treatments. Overall, NGS genetic testing can provide valuable information for diagnosing Dravet syndrome and identifying potential modifiers. This information can help doctors develop personalized treatment plans for patients with this condition.